Basal Insulin Market
According to Intent Market Research, the Basal Insulin Market is expected to grow from USD 14.7 billion in 2023 at a CAGR of 8.0% to touch USD 25.2 billion by 2030. The Basal Insulin Market is dominated by key players such as, Novo Nordisk, Sanofi, Merck & Co., Pfizer Inc., and Johnson & Johnson.